Evaluation of tuberculosis laboratory sending and reporting for new and relapse pulmonary tuberculosis cases in community hospitals of Nakhon Ratchasima Province during fiscal year 2019

Authors

  • Nuttakoon Chaisongkram Mae Tha Hospital, Lampang Province, Thailand
  • Rapeepong Suphanchaimat Division of Epidemiology, Department of Disease Control Ministry of Public Health, Thailand
  • Petchawan Pungrassami Office of the Honorable Commission, Department of Disease Control
  • Sattawat Sanmai Office of Disease Prevention and Control Region 9, Nakhon Ratchasima Province, Department of Disease Control
  • Inchat Sukkasem Office of Disease Prevention and Control Region 9, Nakhon Ratchasima Province, Department of Disease Control
  • Chuleeporn Jiraphongsa Office of the Honorable Commission, Department of Disease Control

DOI:

https://doi.org/10.59096/wesr.v53i39.3439

Keywords:

evaluation, laboratory, tuberculosis, Nakhon Ratchasima

Abstract

Introduction: The national Tuberculosis Control Programme Guideline (NTCPG), Thailand, 2018 recommended molecular techniques to assist the diagnosis of tuberculosis and drug-resistant tuberculosis. The objective of this study is to describe and evaluate the tuberculosis laboratory sending and reporting systems in new and relapse pulmonary tuberculosis in community hospitals of Nakhon Ratchasima Province in fiscal year 2019.

Methods: A descriptive cross–sectional study was applied. We reviewed the medical records of new and relapse pulmonary tuberculosis (PTB), who registered in 3 community hospitals, from National Tuberculosis Information Program and Hospital information Program as well as described tuberculosis laboratory system by interviewing with 16 stakeholders.

Results: Among 142 new PTB, the coverage of sending sputum for culture and DST in patients with AFB positive was 91.5%, and the coverage of Xpert MTB/RIF sending for patients with AFB negative was 66.7%. Among 15 relapse PTB, the coverage of sending sputum for culture and DST in patients with AFB positive was 22.2%, and the coverage of sending sputum for culture and DST with Xpert MTB/RIF in AFB negative was 66.7%. Data from 158 specimens sending revealed the median of laboratory turnaround time for culture, DST, Xpert MTB/RIF and LPA were 8 weeks (Q1–Q3 = 6–10), 14 weeks (Q1–Q3 = 11–17), 11.5 days (Q1–Q3 = 6–30.5) and 15.5 days (Q1–Q3 = 9–19), respectively.

Conclusion: The coverage of drug susceptibility testing in newly diagnosed and relapse pulmonary tuberculosis patients, of the three community hospitals in Nakhon Ratchasima province, 2019, achieved the national target set by Thailand Operational Plan to End TB 2017–2021. The reporting time for culture and drug susceptibility testing results has followed the national guidelines, but for Xpert and LPA, it took longer than the time specified in the national guidelines. Therefore, there should be a review and adjustment of work processes to ensure that the reporting time aligns with the NTCPG.

References

World Health Organization. WHO global lists of high burden countries for TB, multidrug/rifampicin-resistant TB (MDR/RR-TB) and TB/HIV, 2021–2025. Geneva: World Health Organization; 2021.

World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.

Department of Disease Control (TH), Division of Tuberculosis. Thailand Operation Plan to End Tuberculosis 2017-2021. Bangkok: Division of Tuberculosis; 2017. (in Thai)

Department of Disease Control (TH), Division of Tuberculosis. National Tuberculosis Control Programme Guideline, Thailand, 2018. Bangkok: Division of Tuberculosis; 2018. (in Thai)

Department of Disease Control (TH), Division of Tuberculosis. TBCM Thailand Bangkok: Division of Tuberculosis; 2020. [cited 2020 Apr 22]. Available from: https://ntip-ddc.moph.go.th/uiform/Login.aspx (in Thai)

Tatiyanantaporn S, Nasungnoen B. A comparative Study on Duration from MDR-TB Diagnosis and Phenotypic DST: A Case Study from Nakhon Ratchasima Province 1st October 2012-31st March 2017. The Office of Disease Prevention and Control 9th Nakhon Ratchasima Journal. 2018; 24(1): 34–41. (in Thai)

Nakhon Ratchasima Provincial Health Office. Guideline for Diagnosis New Tuberculosis and Drug-resistant Tuberculosis in Nakhon Ratchasima Province during fiscal year 2016-2017. Nakhon Ratchasima: Nakhon Ratchasima Provincial Health Office; 2017. (in Thai)

Rattanadilok Na Bhuket J. Evaluation of Tuberculosis Drug Resistant Testing Coverage in the Lower Part of Southern Thailand. Journal of Bamrasnaradura Infectious Diseases Institute. 2019; 13(3): 171–81. (in Thai)

Lee PH, Chan PC, Peng YT, Chu P-W, Wu MH, Jou R, et al. Impact of universal drug susceptibility testing and effective management of multidrug-resistant tuberculosis in Taiwan. PLoS ONE. 2019; 14(4): e0214792.

Department of Disease Control (TH), Division of Tuberculosis. Project to Stop Tuberculosis and AIDS through Reach-Recruit-Test-Treat-Retain: RRTTR. Bangkok: Division of Tuberculosis; 2015. (in Thai)

National Health Security Office (TH). Ha ndbook of Health Insurance Fund, Fiscal year 2019. Nonthaburi: National Health Security Office; 2018. (in Thai)

Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA. Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bulletin of the World Health Organization. 2007; 85(5): 354–9.

Downloads

Published

2022-10-07

How to Cite

Chaisongkram, N., Suphanchaimat, R., Pungrassami, P., Sanmai, S., Sukkasem, I., & Jiraphongsa, C. (2022). Evaluation of tuberculosis laboratory sending and reporting for new and relapse pulmonary tuberculosis cases in community hospitals of Nakhon Ratchasima Province during fiscal year 2019. Weekly Epidemiological Surveillance Report, 53(39), 591–601. https://doi.org/10.59096/wesr.v53i39.3439

Issue

Vol. 53 No. 39 (2022): 39 Week

Section

Original article

License

Copyright (c) 2022 Weekly Epidemiological Surveillance Report

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Responsibility and Copyright

1. Author Responsibility and Editorial Disagreement

The content and data in all articles published in WESR are the direct opinions and responsibility of the article authors, and the Journal's Editorial Board is not necessarily in agreement with, or jointly responsible for, them.

2. Copyright and Referencing

All articles, data, content, figures, etc., published in WESR are considered the copyright of the academic journal. If any individual or entity wishes to disseminate all or any part of the published material, appropriate citation of the article is required.